TIA
BHC icon

Traphagen Investment Advisors’s Bausch Health BHC Stock Holding History

Traphagen Investment Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,500
Closed -$302K – 130
2020
Q2 		$302K Buy
16,500
+75
+0.5% +$1.32K 0.07% 95
2020
Q1 		$255K Buy
16,425
+1,090
+7% +$26.3K 0.07% 100
2019
Q4 		$459K Sell
15,335
-1,040
-6% -$27K 0.11% 75
2019
Q3 		$358K Hold
16,375
– – 0.09% 81
2019
Q2 		$413K Hold
16,375
– – 0.11% 71
2019
Q1 		$404K Buy
+16,375
New +$391K 0.11% 69

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Traphagen Investment Advisors's BHC Position: Q3 2020 in Review

Traphagen Investment Advisors sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 16,500 shares — an estimated $302K sold.

Traphagen Investment Advisors first reported a position in BHC in Q1 2019 and held it in 6 quarters. The position peaked at $459K in Q4 2019. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

  • Traphagen Investment Advisors reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
  • Traphagen Investment Advisors sold 16,500 Bausch Health shares in Q3 2020, an estimated $302K.
  • Traphagen Investment Advisors first reported a position in Bausch Health in Q1 2019 and held it in 6 quarters.
  • Traphagen Investment Advisors's Bausch Health position peaked at $459K in Q4 2019.
  • 324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on Traphagen Investment Advisors's 13F filing for Q3 2020, filed 17 Jun 2024.